Effect of Wobenzym in the complex therapy on the kidney functional activity.
The investigations performed showed that in the pregnant women with CP and CG there is noted response to therapy performed in accordance with level of kidney function activity. In the pregnant women with CP and CG the treatment efficacy was higher in pregnant women with KFR > 10% and from 5 to 10% and from 5% to 10%, and practically absent in pregnant women with KFR < 5%.
Zufarova
Sh A
ShA
Tashkent Medical Pediatric Institute.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D004338:Drug Combinations; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006867:Hydrolases / Q000008:administration & dosage / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D007677:Kidney Function Tests; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D011704:Pyelonephritis / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D012431:Rutin / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D012431:Rutin; C023295:Wobenzym; D006867:Hydrolases